Mulago hospital Acute Care Unit and the Cerebral Malaria Project
Kampala, 7051, Uganda
NCT Number: NCT00658450
The purpose of this study is to determine whether computerised cognitive rehabilitation training improves cognition in children who have had cerebral malaria.
Looking for future studies?
Notify Me5 year–15 year
All sexes
Interventional
Not applicable
Kampala, 7051, Uganda
Cerebral malaria affects several children in sub-Saharan Africa leaving some survivors with cognitive problems especially in attention and memory. There are currently no tested interventions for such deficits resulting from infectious diseases like malaria or other causes. Providing such interventions will go a long way in helping these children achieve their full potential.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
CM group Inclusion Criteria:
CM group Exclusion Criteria:
Healthy control group Inclusion Criteria:
Healthy control group Exclusion Criteria:
A computerised cognitive training package where children will be required to complete several cognitive tasks. The aim is to strengthen the different cognitive processes during these tasks which in turn may lead to improve cognitive processes.
Children will complete these tasks in 16 session for 8 weeks.
Other names: Intervention group
Time frame: 6 months
Time frame: 6 months
Makerere University
Other
A Randomised Trial to Investigate the Effect of a Rehabilitation Program for Cognitive Deficits in Ugandan Children After Cerebral Malaria.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03300648
Central Nervous System Diseases, Central Nervous System Infections
Blantyre, Malawi
View Trial DetailsNCT00292942
Central Nervous System Diseases, Central Nervous System Infections
Bethesda, Maryland, United States
View Trial DetailsNCT00292929
Central Nervous System Diseases, Central Nervous System Infections
Bethesda, Maryland, United States
View Trial DetailsNCT01388842
Central Nervous System Diseases, Central Nervous System Infections
Mbarara, Uganda
View Trial Details